epigallocatechin gallate has been researched along with Hepatic Failure in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, R; Wang, J; Wang, X; Wu, X; Yang, CS; Yang, L; Zhang, J; Zhang, Y; Zhang, Z | 1 |
1 other study(ies) available for epigallocatechin gallate and Hepatic Failure
| Article | Year |
|---|---|
A mouse model of subacute liver failure with ascites induced by step-wise increased doses of (-)-epigallocatechin-3-gallate.
Topics: Acute Disease; Animals; Antioxidants; Apoptosis; Aquaporin 2; Ascites; Catechin; Disease Models, Animal; Kidney; Liver; Liver Failure; Male; Membrane Transport Proteins; Mice; Urea Transporters | 2019 |